Insmed Inc (INSM)
26.07
+0.12
(+0.46%)
USD |
NASDAQ |
May 07, 16:00
26.07
0.00 (0.00%)
After-Hours: 16:58
Insmed Profit Margin (Quarterly): -222.3% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -222.3% |
September 30, 2023 | -201.0% |
June 30, 2023 | -317.0% |
March 31, 2023 | -245.0% |
December 31, 2022 | -270.0% |
September 30, 2022 | -193.6% |
June 30, 2022 | -146.6% |
March 31, 2022 | -178.2% |
December 31, 2021 | -201.3% |
September 30, 2021 | -241.1% |
June 30, 2021 | -258.6% |
March 31, 2021 | -227.9% |
December 31, 2020 | -246.8% |
September 30, 2020 | -145.9% |
June 30, 2020 | -145.6% |
March 31, 2020 | -180.0% |
December 31, 2019 | -115.9% |
September 30, 2019 | -156.1% |
June 30, 2019 | -221.9% |
March 31, 2019 | -338.6% |
December 31, 2018 | -931.1% |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | -76.99% |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | -581.8% |
September 30, 2011 | -7.95K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-317.0%
Minimum
Jun 2023
-115.9%
Maximum
Dec 2019
-206.0%
Average
-201.3%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
NeuroMetrix Inc | -125.2% |
Intra-Cellular Therapies Inc | -21.73% |
Rhythm Pharmaceuticals Inc | -171.8% |
Amylyx Pharmaceuticals Inc | 4.36% |
AN2 Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -51.57% |
Return on Invested Capital | -75.46% |
Gross Profit Margin (Quarterly) | 77.96% |
Operating Margin (Quarterly) | -194.2% |
Return on Net Operating Assets | -180.6% |